Imaging synaptic density in depression
Open accessThe DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
Abstract
Major depressive disorder is a prevalent and heterogeneous disorder with treatment resistance in at least 50% of individuals. Most of the initial studies focused on the monoamine system; however, recently other mechanisms have come under investigation. Specific to the current issue, studies show synaptic involvement in depression. Other articles in this issue report on reductions in synaptic density, dendritic spines, boutons and glia associated with stress and depression. Importantly, it appears that some drugs (e.g., ketamine) may lead to rapid synaptic restoration or synaptogenesis. Direct evidence for this comes from preclinical work. However, neuroimaging studies, such as magnetic resonance imaging (MRI) and positron emission tomography (PET), have become useful in assessing these changes in vivo. Here, we describe the use of neuroimaging techniques in the evaluation of synaptic alterations associated with depression in humans, as well as measurement of synaptic restoration after administration of ketamine. Although more research is desired, use of these techniques widen our understanding of depression and move us further along the path to targeted and effective treatment for depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Hippocampal Volume Reduction in Major Depression
Bremner, J. D., Narayan, M., Anderson, E. R., Staib, L. H., Miller, H. L., & Charney, D. S. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.115 · Cited by 1,670
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.7.973 · Cited by 1,610 · cited 1×
“Reduction in hippocampal volumes is one of the earliest and most replicated sMRI evidence of gray matter deficits in MDD and other stress-related disorders [18, 19].”
Backgroundfor the ENIGMA-Major Depressive Disorder Working Group, Schmaal, L., Hibar, D. P., Sämann, P. G., Hall, G. B., Baune, B. T., Jahanshad, N., Cheung, J. W., van Erp, T. G. M., Bos, D., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.60 · Cited by 1,330
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Updated Energy Budgets for Neural Computation in the Neocortex and Cerebellum
Howarth, C., Gleeson, P., & Attwell, D. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.35 · Cited by 738
Liang, X., Zou, Q., He, Y., & Yang, Y. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214900110 · Cited by 677 · cited 1×
“, global brain connectivity) were found to be positively associated with regional cerebral blow flow [11, 12] and glutamate neurotransmission [13].”
BackgroundSanacora, G., Mason, G. F., Rothman, D. L., Behar, K. L., Hyder, F., Petroff, O. A. C., Berman, R. M., Charney, D. S., & Krystal, J. H. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.11.1043 · Cited by 627
Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT
Sanacora, G., Mason, G. F., Rothman, D. L., Hyder, F., Ciarcia, J. J., Ostroff, R. B., Berman, R. M., & Krystal, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.577 · Cited by 513
Lower synaptic density is associated with depression severity and network alterations
Holmes, S. E., Scheinost, D., Finnema, S. J., Naganawa, M., Davis, M. T., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G. A., Pietrzak, R. H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09562-7 · Cited by 484
Self-citationVidebech, P. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.101001011.x · Cited by 419
Research works printed but not linked: 1
- Abdallah C, Mason G, DellaGioia N, Sanacora G, Jiang L, Matuskey D, et al. mGluR5 and glutamate involvement in MDD: a multimodal imaging study. Biol Psychiatry. 2017;2:449–56.
Cited by
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Microglial‐Biomimetic Memantine‐Loaded Polydopamine Nanomedicines for Alleviating Depression
Jiang, C., Yang, X., Huang, Q., Lei, T., Luo, H., Wu, D., Yang, Z., Xu, Y., Dou, Y., Ma, X., et al. (2025) · Advanced Materials · doi:10.1002/adma.202417869 · Cited by 55
Synaptic changes in psychiatric and neurological disorders: State-of-the art of in vivo imaging
Howes, O., Marcinkowska, J., Turkheimer, F. E., & Carr, R. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-024-01943-x · Cited by 34
Chen, B., Jin, K., Dong, J., Cheng, S., Kong, L., Hu, S., Chen, Z., & Lü, J. (2024) · Advanced Science · doi:10.1002/advs.202405354 · Cited by 43
Targeting Neuroplasticity in Substance Use Disorders: Implications for Therapeutics
Wolf, M. E. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-061724-080548 · Cited by 27
Metadata
- Authors
- Holmes, S. E., Abdallah, C., & Esterlis, I.
- Affiliations
- Yale University (US)
- Baylor College of Medicine (US)
- Corresponding author
- Esterlis, Irina
- Venue
- Neuropsychopharmacology
- Published
- 2022-06-29
- Volume
- 48
- Issue
- 1
- Pages
- 186-190
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC9700860
- OpenAlex
- W4283763677
- Semantic Scholar
- 3832d4a4eb999346e06f3dccb7de3e181477e5b4
- Cited by
- 39
- References
- 52
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 11 · 2023: 7 · 2022: 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- Funders
- Veterans Affairs National Center for PTSD
- U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH104459)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- major depressive disorder, synaptic density, ketamine, synaptogenesis, dendritic spines, glia, stress, treatment-resistant depression, magnetic resonance imaging, positron emission tomography
- MeSH terms
- Depression, Depressive Disorder, Major, Major Depressive Disorder, Humans, Ketamine, Positron-Emission Tomography, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Imaging synaptic density in depression. https://app.cochat.ai/papers/10.1038/s41386-022-01368-4
- The paper
- Holmes, S. E., Abdallah, C., & Esterlis, I. (2023). Imaging synaptic density in depression. Neuropsychopharmacology. https://doi.org/10.1038/s41386-022-01368-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.